New analytical methods for the determination of Bendamustine hydrochloride: An antineoplastic drug

Journal of Chemical and Pharmaceutical Research

Volumn 4, Issue 3, 2012, Pages 1696-1701

  Annapurna, M Mathrusri ^a   Pavani, S ^a   Anusha, S ^a   Mahanti, Harika ^a   Venkatesh, B ^a  

^a GITAM UNIVERSITY   (India)

Author keywords

Bendamustine hydrochloride; Difference spectroscopy; ICH; Validation

Indexed keywords

ABSORPTION MAXIMA; ANALYTICAL METHOD; ANTINEOPLASTIC DRUGS; BENDAMUSTINE HYDROCHLORIDE; CHRONIC LYMPHOCYTIC LEUKEMIAS; CONCENTRATION RANGES; DIFFERENCE SPECTROSCOPY; ICH; NITROGEN MUSTARDS; PHARMACEUTICAL DOSAGE FORMS; PHARMACEUTICAL FORMULATION; PHOSPHATE BUFFERS; REGRESSION EQUATION; SPECTRO-PHOTOMETRIC METHOD; VALIDATION;

IONIZATION OF GASES; SPECTRUM ANALYSIS;

REGRESSION ANALYSIS;

ANTINEOPLASTIC AGENT; BENDAMUSTINE; BENDIT; BORIC BUFFER; BUFFER; PHOSPHATE BUFFER; PURPLZ; UNCLASSIFIED DRUG;

ABSORPTION MAXIMA; ABSORPTION SPECTROSCOPY; ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; INTERMETHOD COMPARISON; LINEARITY; PH; VALIDATION STUDY;

EID: 84859592840     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. JW Friedberg; P Cohen; L Chen; KS Robinson; A Forero-Torres; AS La Casce; LE Fayad; A Bessudo; ES Camacho; ME Williams; RH van der Jagt; JW Oliver; BD Cheson. J. Clinical Oncology. 2008, 26(2), 204.
2. J Teichert; R Sohr; F Baumann; L Hennig; K Merkle; K Caca; R Preiss. Drug Metab. Dispos. 2005, 33, 984.
3. V Gandh. Semin. Oncol. 2002, 29, 4.
4. J Teichert; F Baumann; Q Chao; C Franklin; B Bailey; L Hennig; K Caca; K Schoppmeyer; U Patzak; R Preiss. Cancer Chemother. Pharmacol. 2007, 59, 759.
5. M Rasschaert; D Schrijvers; J Van den Brande; J Dyck; J Bosmans; K Merkle. J Vermorken, Br. J. Cancer. 2007, 96, 1692.
6. R Preiss; R Sohr; M Matthias; B Brockmann; H Huller. Pharmazie 1985, 40, 782.
7. T Lissitchkov; G Arnaudov; D Peytchev, Merkle Kh. J. Cancer Research and Clinical Oncology. 2006, 132 (2), 99.
8. Ivanka Pencheva; Anita Bogomilova; Neli Koseva; Danka Obreshkova; Kolio Troev. J. Pharm. Biomed. Analysis, 2008, 48, 1143.
9. Validation of Analytical Procedures: Methodology (Q2B), ICH Harmonized Tripartite Guidelines, Geneva, 1996.
10. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceutical for Human Use: Validation of Analytical procedures, Text and methodology - Q2 (R1), 2005.